Materiovigilance: Current status in India analogous to its global status
Journal Title: Journal of Pharmacovigilance and Drug Research - Year 2020, Vol 1, Issue 20201204
Abstract
Medical devices are boon to the healthcare system and are available in the market since long ago. More than 500,000 different types of the medical devices are available in the international market. Thus, from the patient safety view point, assessment of the quality and safety of these medical devices is essential. To address the aforesaid issue International Medical Device Regulators Forum (IMDF) was established in 2011 was established at international Level. In India, 4 years later in 2015, Materiovoigilance Program of india (MvPI) was introduced with the prime aim of improving the protection of the health and safety of patients, healthcare professionals and others by reducing the likelihood of reoccurrence of an adverse event associated with the use of medical devices. At present, there are 50 Medical Device Adverse Event Monitoring Centres (MDMCs) in India. Every country has its own regulatory body and guidelines for monitoring and reporting of adverse events due to medical devices eg: USFDA in USA, TGA in Australia, MHRA in UK, ENVISA in Brazil, CDSCO in India etc. In India, the provisions of regulation of safety, quality and performance of medical devices are laid down in the Drugs and Cosmetics Act, 1940 and rules 1945. This review article discusses the classification and regulation of medical devices in India and the world with framework of adverse event reporting system for medical devices in India.
Authors and Affiliations
Nalini Pandey1*, Mohammed Imran 2
Keywords
Related Articles
- EP ID EP690859
- DOI 10.5281/zenodo.4299028
- Views 194
- Downloads 0
Artificial Neural Network: A Data Mining Tool in Pharmacovigilance
Pharmacovigilance ensures patients safety as well as drug safety. In India, there is still a lot to be done and learned to ensure that the work and activities done in the area of pharmacovigilance are safely implemented....
Toxic epidermal necrolysis associated with combination therapy of spironolactone and torsemide
Dytor plus tablet is a fixed-dose combination of torsemide and spironolactone used for generalized edema. TEN is a serious, potentially life-threatening dermatological disorder. Here we present a case report of a 47-year...
A Review on Potential Drug Delivery System as a Treatment of Intercellular Bacterial Infection
Intracellular bacterial pathogens are hard to treat because of the inability of conventional antimicrobial agents belonging to widely used classes, like aminoglycosides and β-lactams, fluoroquinolones, or macrolides to p...
Drug Related Problems on Anti-platelets and Anti-coagulants in Stroke
The aim of the research work is to access, evaluate and monitor the drug related problems on antiplatelet and anticoagulants in stroke patients. Antiplatelet agents prevent platelets from dumping and prevent clots from f...
Design, synthesis, characterization and in vivo studies of some hydroxylated chalcone derivatives as hypoglycemic agents
Low molecular weight ligands (LMWL) have citadel reputation in the modulation of numerous therapeutic targets as a result of their smart uniqueness. The hydroxylated chalcone derivatives have been reported to be therapeu...